Health Condition 1: K641- Second degree hemorrhoids
Conditions
Interventions
None listed
Sponsors
Gaurav Umesh Sachdev
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of age group 18 to 50 years. 2.Patients of both genders are accepted. 3.Patients diagnosed with Abhayantar Arsha [First and Second degree Haemorrhoids) will be selected. 4.Patients who provide written consent. 5.Individuals experiencing Haemorrhoidal symptom (pain, bleeding prolapse) for atleast 4 weeks.
Exclusion criteria
Exclusion criteria: 1.Patient with Haemoglobin less than 8gm%. 2.With known case of 3rd an 4th degree hemorrhoids,fissure,fistula,prolapsed rectum. 3.Patient with severe systemic illness such as HTN,Uncontrolled DM,CVD and HIV and Immunocompromised patients. 4.Pregnant And lactating mother. 5. Patients with active gastrointestinal disease Such as UC,CD,CA.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is to assess the efficacy of oral administration of 250mg Patrakadi Vati with Gudodak twice daily for 28 days in managing Abhyantar Arsha (First and Second Degree Internal Hemorrhoids) by evaluating: Reduction in bleeding episodes, Improvement in constipation, Decrease in anal pain, Regression in pile mass size and number.Timepoint: 0,7th,14th and 28th Day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Duration of symptom relief (pain, constipation, pile mass regression) ,assessed on Day 7, Day 14, & Day 28. 2. Reduction in bleeding episodes measured by frequency & severity of hemorrhoidal bleeding on Day 7, Day 14, & Day 28. 3. Cost-effectiveness analysis comparison of healthcare expenses, treatment duration, & patient recovery time at the end of the study. 4. Objective improvements in hemorrhoidal size & number ,assessed via Proctoscopy on Day 0, Day 7, Day 14, & Day 28.Timepoint: Day 0th,7th,14th & 28th | — |
Countries
India
Contacts
Public ContactDr Naimish Kishor Saraf
Siddhakala Ayurved mahavidyalay, Sangamner
Outcome results
None listed